<Page>

                                                                    EXHIBIT 10.2

                                                                  EXECUTION COPY

                                  $275,000,000

                              AMY ACQUISITION CORP.

                    10 1/2% SENIOR SUBORDINATED NOTES DUE 2013

                          REGISTRATION RIGHTS AGREEMENT

                                                                   March 27,2003

CREDIT SUISSE FIRST BOSTON LLC
DEUTSCHE BANK SECURITIES INC.
WACHOVIA SECURITIES, INC,
 c/o Credit Suisse First Boston LLC.
    Eleven Madison Avenue,
      New York, New York 10010-3629

Dear Sirs:

     Amy Acquisition Corp., a Delaware corporation (the "COMPANY"), proposes to
issue and sell to Credit Suisse First Boston LLC, Deutsche Bank Securities Inc.
and Wachovia Securities, Inc. (collectively, the "INITIAL PURCHASERS"), upon the
terms set forth in a Purchase Agreement dated as of March 13,2003 (the "PURCHASE
AGREEMENT"), $275,000,000 aggregate principal amount of its 101/2% Senior
Subordinated Notes Due 2013 (the "INITIAL SECURITIES") to be guaranteed (the
"GUARANTIES") by each of the subsidiaries of the Company listed in Schedule I
hereto (the "GUARANTORS"). The Initial Securities will be issued pursuant to an
Indenture dated as of the date hereof (the "INDENTURE"), among the Company, the
Guarantors and U.S. Bank National Association, as trustee (the "TRUSTEE"). As an
inducement to the Initial Purchasers to enter into the Purchase Agreement, the
Company and the Guarantors have agreed to enter into this Agreement. Following
the closing of the Merger (as defined in the Purchase Agreement), references in
this Agreement to the Company will mean AmeriPath, as the surviving company in
the Merger. Accordingly, the Company and the Guarantors agree with the Initial
Purchasers, for the benefit of the Initial Purchasers and the holders of the
Securities (as defined below) (collectively the "HOLDERS"), as follows:

     1.   REGISTERED EXCHANGE OFFER. Unless not permitted by applicable law
(after the Company has complied with the ultimate paragraph of this Section 1),
the Company shall prepare and, not later than 90 days (such 90th day being a
"FILING DEADLINE") after the date on which the Initial Purchasers purchase the
Initial Securities pursuant to the Purchase Agreement (the "CLOSING DATE"), file
with the Securities and Exchange Commission (the "COMMISSION") a registration
statement (the "EXCHANGE OFFER REGISTRATION STATEMENT") on an appropriate form
under the Securities Act of 1933, as amended (the "SECURITIES ACT"), with
respect to a proposed offer (the "REGISTERED EXCHANGE OFFER") to the Holders of
Transfer Restricted Securities (as defined in Section 6 hereof), who are not
prohibited by any law or policy of the Commission from participating in the
Registered Exchange Offer, to issue and deliver to such Holders, in exchange for
the Initial Securities, a like aggregate principal amount of debt securities of
the Company issued under the Indenture, identical in all material respects to
the Initial Securities (except that the Exchange Securities will not contain
terms with respect to transfer restrictions and Additional Interest) and
registered under the Securities Act (the "EXCHANGE SECURITIES"). The Company
shall use its reasonable best efforts to (i) cause such Exchange Offer
Registration Statement to become effective under the Securities Act within 180
days after the Closing Date (such 180th day being an "EFFECTIVENESS DEADLINE")
and (ii) keep the Exchange Offer Registration Statement effective for not less
than 30 days (or

<Page>

                                                                               2

longer, if required by applicable law) after the date notice of the Registered
Exchange Offer is mailed to the Holders (such period being called the "EXCHANGE
OFFER REGISTRATION PERIOD").

     If the Company commences the Registered Exchange Offer, the Company (i)
will be entitled to consummate the Registered Exchange Offer 30 days after such
commencement (PROVIDED that the Company has accepted all the Initial Securities
theretofore validly tendered in accordance with the terms of the Registered
Exchange Offer) and (ii) will be required to consummate the Registered Exchange
Offer no later than 40 days after the date on which the Exchange Offer
Registration Statement is declared effective (such 40th day being the
"CONSUMMATION DEADLINE").

     Following the declaration of the effectiveness of the Exchange Offer
Registration Statement, the Company shall as soon as practicable commence the
Registered Exchange Offer, it being the objective of such Registered Exchange
Offer to enable each Holder of Transfer Restricted Securities electing to
exchange the Initial Securities for Exchange Securities (assuming that such
Holder is not an affiliate of the Company within the meaning of the Securities
Act, acquires the Exchange Securities in the ordinary course of such Holder's
business and has no arrangements with any person to participate in the
distribution of the Exchange Securities and is not prohibited by any law or
policy of the Commission from participating in the Registered Exchange Offer) to
trade such Exchange Securities from and after their receipt without any
limitations or restrictions under the Securities Act and without material
restrictions under the securities laws of the several states of the United
States.

     The Company acknowledges that, pursuant to current interpretations by the
Commission's staff of Section 5 of the Securities Act, in the absence of an
applicable exemption therefrom, (i) each Holder which is a broker-dealer
electing to exchange Initial Securities, acquired for its own account as a
result of market making activities or other trading activities, for Exchange
Securities (an "EXCHANGING DEALER"), is required to deliver a prospectus
containing the information set forth in (a) Annex A hereto on the cover, (b)
Annex B hereto in the "Exchange Offer Procedures" section and the "Purpose of
the Exchange Offer" section and (c) Annex C hereto in the "Plan of Distribution"
section of such prospectus in connection with a sale of any such Exchange
Securities received by such Exchanging Dealer pursuant to the Registered
Exchange Offer and (ii) an Initial Purchaser that elects to sell Securities (as
defined below) acquired in exchange for Initial Securities constituting any
portion of an unsold allotment, is required to deliver a prospectus containing
the information required by Items 507 or 508 of Regulation S-K under the
Securities Act, as applicable, in connection with such sale.

     The Company shall use its reasonable best efforts to keep the Exchange
Offer Registration Statement effective and to amend and supplement the
prospectus contained therein, in order to permit such prospectus to be lawfully
delivered by all persons subject to the prospectus delivery requirements of the
Securities Act for such period of time as such persons must comply with such
requirements in order to resell the Exchange Securities; PROVIDED, HOWEVER, that
(i) in the case where such prospectus and any amendment or supplement thereto
must be delivered by an Exchanging Dealer or an Initial Purchaser, such period
shall be the lesser of 180 days and the date on which all Exchanging Dealers and
the Initial Purchasers have sold all Exchange Securities held by them (unless
such period is extended pursuant to Section 3(j) below) and (ii) the Company
shall make such prospectus and any amendment or supplement thereto available to
any broker-dealer for use in connection with any resale of any Exchange
Securities for a period of not less than 180-days after the consummation of the
Registered Exchange Offer.

<Page>

                                                                               3

     If, upon consummation of the Registered Exchange Offer, any Initial
Purchaser holds Initial Securities acquired by it as part of its initial
distribution, the Company, simultaneously with the delivery of the Exchange
Securities pursuant to the Registered Exchange Offer, shall issue and deliver to
such Initial Purchaser upon the written request of such Initial Purchaser, in
exchange (the "PRIVATE EXCHANGE") for the Initial Securities held by such
Initial Purchaser, a like principal amount of debt securities of the Company
issued under the Indenture and identical in all material respects to the Initial
Securities (the "PRIVATE EXCHANGE Securities"). The Initial Securities, the
Exchange Securities and the Private Exchange Securities are herein collectively
called the "SECURITIES".

     In connection with the Registered Exchange Offer, the Company shall:

          (a)  mail to each Holder a copy of the prospectus forming part of the
     Exchange Offer Registration Statement, together with an appropriate letter
     of transmittal and related documents, provided that the Company shall only
     be required to mail such prospectus to Holders of which the Company is
     aware after due inquiry;

          (b)  keep the Registered Exchange Offer open for not less than 30 days
     (or longer, if required by applicable law) after the date notice thereof is
     mailed to the Holders;

          (c)  utilize the services of a depositary for the Registered Exchange
     Offer with an address in the Borough of Manhattan, The City of New York,
     which may be the Trustee or an affiliate of the Trustee;

          (d)  permit Holders to withdraw tendered Securities at anytime prior
     to the close of business, New York time, on the last business day on which
     the Registered Exchange Offer shall remain open; and

          (e)  otherwise comply in all material respects with all applicable
     laws.

     As soon as practicable after the close of the Registered Exchange Offer or
the Private Exchange, as the case may be, the Company shall:

          (x)  accept for exchange all the Securities validly tendered and not
     withdrawn pursuant to the Registered Exchange Offer and the Private
     Exchange;

          (y)  deliver to the Trustee for cancelation all the Initial Securities
     so accepted for exchange; and

          (z)  cause the Trustee to authenticate and deliver promptly to each
     Holder of the Initial Securities, Exchange Securities or Private Exchange
     Securities, as the case may be, equal in principal amount to the Initial
     Securities of such Holder so accepted for exchange.

     The Indenture will provide that the Exchange Securities will not be subject
to the transfer restrictions set forth in the Indenture and that all the
Securities will vote and consent together on all matters as one class and that
none of the Securities will have the right to vote or consent as a class
separate from one another on any matter.

     Interest on each Exchange Security and Private Exchange Security issued
pursuant to the Registered Exchange Offer and in the Private Exchange will
accrue from the last interest payment date on which interest was paid on the
Initial Securities surrendered in exchange

<Page>

                                                                               4

therefor or, if no interest has been paid on the Initial Securities, from the
date of original issue of the Initial Securities.

     Each Holder participating in the Registered Exchange Offer shall be
required to represent to the Company that at the time of the consummation of the
Registered Exchange Offer (i) any Exchange Securities received by such Holder
will be acquired in the ordinary course of business, (ii) such Holder will have
no arrangements or understanding with any person to participate in the
distribution of the Securities or the Exchange Securities within the meaning of
the Securities Act, (iii) such Holder is not an "affiliate", as defined in Rule
405 of the Securities Act, of the Company or if it is an affiliate, such Holder
will comply with the registration and prospectus delivery requirements of the
Securities Act to the extent applicable, (iv) if such Holder is not a
broker-dealer, that it is not engaged in, and does not intend to engage in, the
distribution of the Exchange Securities and (v) if such Holder is a
broker-dealer, that it will receive Exchange Securities for its own account in
exchange for Initial Securities that were acquired as a result of market-making
activities or other trading activities and that it will be required to
acknowledge that it will deliver a prospectus in connection with any resale of
such Exchange Securities.

     Notwithstanding any other provisions hereof, the Company will ensure that
(i) any Exchange Offer Registration Statement and any amendment thereto and any
prospectus forming part thereof and any supplement thereto complies in all
material respects with the Securities Act and the rules and regulations
thereunder, (ii) any Exchange Offer Registration Statement and any amendment
thereto does not, when it becomes effective, contain an untrue statement of a
material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading and (iii) any prospectus
forming part of any Exchange Offer Registration Statement, and any supplement to
such prospectus, does not include an untrue statement of a material fact or omit
to state a material fact required to be stated therein or necessary in order to
make the statements therein, in the light of the circumstances under which they
were made, not misleading.

     If following the date hereof there has been announced a change in
Commission policy with respect to exchange offers that in the reasonable opinion
of counsel to the Company raises a substantial question as to whether the
Registered Exchange Offer is permitted by applicable federal law, the Company
will seek a no-action letter or other favorable decision from the Commission
allowing the Company to consummate the Registered Exchange Offer. The Company
will pursue the issuance of such a decision to the Commission staff level. In
connection with the foregoing, the Company will take all such other actions as
may be requested by the Commission or otherwise required in connection with the
issuance of such decision, including without limitation (i) participating in
telephonic conferences with the Commission, (ii) delivering to the Commission
staff an analysis prepared by counsel to the Company setting forth the legal
bases, if any, upon which such counsel has concluded that the Registered
Exchange Offer should be permitted and (iii) diligently pursuing a resolution
(which need not be favorable) by the Commission staff.

     2.   SHELF REGISTRATION. If, (i) because of any change in law or in
applicable interpretations thereof by the staff of the Commission, the Company
is not permitted to effect a Registered Exchange Offer, as contemplated by
Section 1 hereof, (ii) the Registered Exchange Offer is not consummated by the
220th day after the Closing Date, (iii) any Initial Purchaser so requests with
respect to the Initial Securities (or the Private Exchange Securities) not
eligible to be exchanged for Exchange Securities in the Registered Exchange
Offer and held by it following consummation of the Registered Exchange Offer or
(iv) any Holder (other than an Exchanging Dealer) is not eligible to participate
in the Registered Exchange Offer or, in the case of any Holder (other than an
Exchanging Dealer) that participates in the Registered

<Page>

                                                                               5

Exchange Offer, such Holder does not receive freely tradeable Exchange
Securities on the date of the exchange and any such Holder so requests, the
Company shall take the following actions (the date on which any of the
conditions described in the foregoing clauses (i) through (iv) occur, including
in the case of clauses (iii) or (iv) the receipt of the required notice, being a
"TRIGGER DATE"):

          (a)  The Company shall promptly (but in no event more than 60 days
     after the Trigger Date (such 60th day being a "FILING DEADLINE")) file with
     the Commission and thereafter use its reasonable best efforts to cause to
     be declared effective no later than (1) in the case of clause (i) above,
     180 days after the Closing Date and (2) in the case of clause (ii), (iii)
     and (iv) above, 75 days after the applicable Trigger Date (such 180th day
     or 75th day, as the case maybe, being an "EFFECTIVENESS DEADLINE") a
     registration statement (the "SHELF REGISTRATION STATEMENT" and, together
     with the Exchange Offer Registration Statement, a "REGISTRATION STATEMENT")
     on an appropriate form under the Securities Act relating to the offer and
     sale of the Transfer Restricted Securities by the Holders thereof from time
     to time in accordance with the methods of distribution set forth in the
     Shelf Registration Statement and Rule 415 under the Securities Act
     (hereinafter, the "SHELF REGISTRATION"); PROVIDED, HOWEVER, that no Holder
     (other than an Initial Purchaser) shall be entitled to have the Securities
     held by it covered by such Shelf Registration Statement unless such Holder
     agrees in writing to be bound by all the provisions of this Agreement
     applicable to such Holder (with the Initial Purchasers' agreement thereto
     being evidenced by their execution of this Agreement).

          (b)  Subject to Section 3(j), the Company shall keep the Shelf
     Registration Statement continuously effective in order to permit the
     prospectus included therein to be lawfully delivered by the Holders o f the
     relevant Securities, for a period of two years (or for such longer period
     if extended pursuant to Section 3(j) below) from the date of its
     effectiveness or such shorter period that will terminate when all the
     Securities covered by the Shelf Registration Statement (i) have been sold
     pursuant thereto or (ii) are no longer restricted securities (as defined in
     Rule 144 under the Securities Act, or any successor rule thereof).

          (c)  Notwithstanding any other provisions of this Agreement to the
     contrary, the Company shall cause the Shelf Registration Statement and the
     related prospectus and any amendment or supplement thereto, as of the
     effective date of the Shelf Registration Statement, amendment or
     supplement, (i) to comply in all material respects with the applicable
     requirements of the Securities Act and the rules and regulations of the
     Commission and (ii) not to contain any untrue statement of a material fact
     or omit to state a material fact required to be stated therein or necessary
     in order to make the statements therein, in light of the circumstances
     under which they were made, not misleading; it being understood that the
     Company shall not be so responsible for information provided by or on
     behalf of Holders of Securities.

     3.   REGISTRATION PROCEDURES. In connection with any Shelf Registration
contemplated by Section 2 hereof and, to the extent applicable, any Registered
Exchange Offer contemplated by Section 1 hereof, the following provisions shall
apply:

          (a)  The Company shall (i) if requested in writing, furnish to each
     Initial Purchaser, prior to the filing thereof with the Commission, a copy
     of the Registration Statement and each amendment thereof and each
     supplement, if any, to the prospectus included therein and, in the event
     that an Initial Purchaser (with respect to any portion of an unsold
     allotment from the original offering) is participating in the Registered
     Exchange Offer or the Shelf Registration Statement, the Company shall use
     its

<Page>

                                                                               6

     reasonable best efforts to reflect in each such document, when so filed
     with the Commission, such comments as such Initial Purchaser reasonably may
     propose; (ii) include the information set forth in Annex A hereto on the
     cover, in Annex B hereto in the "Exchange Offer Procedures" section and the
     "Purpose of the Exchange Offer" section and in Annex C hereto in the "Plan
     of Distribution" section of the prospectus forming a part of the Exchange
     Offer Registration Statement and include the information set forth in Annex
     D hereto in the Letter of Transmittal delivered pursuant to the Registered
     Exchange Offer; (iii) if requested by an Initial Purchaser, include the
     information required by Items 507 or 508 of Regulation S-K under the
     Securities Act, as applicable, in the prospectus forming a part of the
     Exchange Offer Registration Statement; (iv) include within the prospectus
     contained in the Exchange Offer Registration Statement a section entitled
     "Plan of Distribution" reasonably acceptable to the Initial Purchasers,
     which shall contain a summary statement of the positions taken or policies
     made by the staff of the Commission with respect to the potential
     "underwriter" status of any broker-dealer that is the beneficial owner (as
     defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended
     (the "EXCHANGE ACT")) of Exchange Securities received by such broker-dealer
     in the Registered Exchange Offer (a "PARTICIPATING BROKER-DEALER"), whether
     such positions or policies have been publicly disseminated by the staff of
     the Commission or such positions or policies, in the reasonable judgment of
     the Initial Purchasers based upon advice of counsel (which maybe in-house
     counsel), represent the prevailing views of the staff of the Commission;
     and (v) in the case of a Shelf Registration Statement, include the names of
     the Holders who propose to sell Securities pursuant to the Shelf
     Registration Statement as selling security holders.

          (b)  The Company shall give written notice to the Initial Purchasers,
     the Holders of the Securities (but in the case of a Shelf Registration,
     only to such Holders as are named as selling securityholders in the
     prospectus forming part of the Shelf Registration Statement) and any
     Participating Broker-Dealer from whom the Company has received prior
     written notice that it will be a Participating Broker-Dealer in the
     Registered Exchange Offer (which notice pursuant to clauses (ii)-(v) hereof
     shall be accompanied by an instruction to suspend the use of the prospectus
     until the requisite changes have been made (any such period of suspension,
     the "Suspension Period")):

               (i) when the Registration Statement or any amendment thereto has
          been filed with the Commission and when the Registration Statement or
          any post-effective amendment thereto has become effective;

               (ii) of any request by the Commission for amendments or
          supplements to the Registration Statement or the prospectus included
          therein or for additional information;

               (iii) of the issuance by the Commission of any stop order
          suspending the effectiveness of the Registration Statement or the
          initiation of any proceedings for that purpose;

               (iv) of the receipt by the Company or its legal counsel of any
          notification with respect to the suspension of the qualification of
          the Securities for sale in any jurisdiction or the initiation or
          threatening of any proceeding for such purpose; and

               (v) of the happening of any event that requires the Company to
          make changes in the Registration Statement or the prospectus in order
          that the

<Page>

                                                                               7

          Registration Statement or the prospectus do not contain an untrue
          statement of a material fact nor omit to state a material fact
          required to be stated therein or necessary to make the statements
          therein (in the case of the prospectus, in light of the circumstances
          under which they were made) not misleading.

          (c)  The Company shall make reasonable efforts to obtain the
     withdrawal at the earliest possible time, of any order suspending the
     effectiveness of the Registration Statement.

          (d)  The Company shal1 furnish to each Holder of Securities included
     within the coverage of the Shelf Registration, without charge, at least one
     copy of the Shelf Registration Statement and any post-effective amendment
     thereto, including financial statements and schedules, and, if the Holder
     so requests in writing, all exhibits thereto (including those, if any,
     incorporated by reference).

          (e)  The Company shall deliver to each Exchanging Dealer and each
     Initial Purchaser, and to any other Holder who so requests in writing,
     without charge, at least one copy of the Exchange Offer Registration
     Statement and any post-effective amendment thereto, including financial
     statements and schedules, and, if any Initial Purchaser or any such Holder
     requests in writing, all exhibits thereto (including those incorporated by
     reference).

          (f)  The Company shall, during the Shelf Registration Period, deliver
     to each Holder of Securities included within the coverage of the Shelf
     Registration, without charge, as many copies of the prospectus (including
     each preliminary prospectus) included in the Shelf Registration Statement
     and any amendment or supplement thereto as such person may reasonably
     request in writing. The Company consents, subject to the provisions of this
     Agreement, to the use of the prospectus or any amendment or supplement
     thereto by each of the selling Holders of the Securities in connection with
     the offering and sale of the Securities covered by the prospectus, or any
     amendment or supplement thereto, included in the Shelf Registration
     Statement.

          (g)  The Company shall deliver to each Initial Purchaser, any
     Exchanging Dealer, any Participating Broker-Dealer and such other persons
     required to deliver a prospectus following the Registered Exchange Offer,
     without charge, as many copies of the final prospectus included in the
     Exchange Offer Registration Statement and any amendment or supplement
     thereto as such persons may reasonably request in writing. The Company
     consents, subject to the provisions of this Agreement, to the use of the
     prospectus or any amendment or supplement thereto by any Initial Purchaser,
     if necessary, any Participating Broker-Dealer and such other persons
     required to deliver a prospectus following the Registered Exchange Offer in
     connection with the offering and sale of the Exchange Securities covered by
     the prospectus, or any amendment or supplement thereto, included in such
     Exchange Offer Registration Statement.

          (h)  Prior to any public offering of the Securities pursuant to any
     Registration Statement the Company shall use its reasonable best efforts to
     register or qualify or cooperate with the Holders of the Securities
     included therein and their respective counsel in connection with the
     registration or qualification of the Securities for offer and sale under
     the securities or "blue sky" laws of such states of the United States as
     any Holder of the Securities reasonably requests in writing and do any and
     all other acts or things reasonably necessary to enable the offer and sale
     in such jurisdictions of the Securities covered by such Registration
     Statement; PROVIDED, HOWEVER, that the Company shall not be required to (i)
     qualify generally to do business in any jurisdiction

<Page>

                                                                               8

     where it is not then so qualified or (ii) take any action which would
     subject it to general service of process or to taxation in any jurisdiction
     where it is not then so subject.

          (i)  The Company shall cooperate with the Holders of the Securities to
     facilitate the timely preparation and delivery of certificates representing
     the Securities to be sold pursuant to any Registration Statement free of
     any restrictive legends and in such denominations and registered in such
     names as the Holders may request a reasonable period of time prior to sales
     of the Securities pursuant to such Registration Statement.

          (j)  Upon the occurrence of any event contemplated by paragraphs (ii)
     through (v) of Section 3(b) above during the period for which the Company
     is required to maintain an effective Registration Statement, the Company
     shall promptly prepare and file a post-effective amendment to the
     Registration Statement or a supplement to the related prospectus and any
     other required document so that, as thereafter delivered to Holders of the
     Securities or purchasers of Securities, the prospectus will not contain an
     untrue statement of a material fact or omit to state any material fact
     required to be stated therein or necessary to make the statements therein,
     in light of the circumstances under which they were made, not misleading.
     If the Company notifies the Initial Purchasers, the Holders of the
     Securities and any known Participating Broker-Dealer in accordance with
     paragraphs (ii) through (v) of Section 3(b) above to suspend the use of the
     prospectus until the requisite changes to the prospectus have been made as
     the case may be, then the Initial Purchasers, the Holders of the Securities
     and any such Participating Broker-Dealers shall suspend use of such
     prospectus (and shall discard or destroy all copies of such prospectus in
     its possession, other than file copies), and the period of effectiveness of
     the Shelf Registration Statement provided for in Section 2(b) above and the
     Exchange Offer Registration Statement provided for in Section 1 above shall
     each be extended by the number of days from and including the date of the
     giving of such notice to and including the date when the Initial
     Purchasers, the Holders of the Securities and any known Participating
     Broker-Dealer shall have received such amended or supplemented prospectus
     pursuant to this Section 3(j). Notwithstanding the foregoing, the Company
     shall not be required to amend or supplement a Registration Statement, any
     related prospectus or any document incorporated therein by reference for a
     period not to exceed an aggregate of 60 days in any calendar year if (i) an
     event occurs and is continuing as a result of which the Shelf Registration
     would, in the Company's good faith judgment, contain an untrue statement of
     a material fact or omit to state a material fact necessary in order to make
     the statements therein, in the light of the circumstances under which they
     were made, not misleading and (ii) (A) the Company determines in its good
     faith judgment that the disclosure of such event at such time would have a
     material adverse effect on the business, operations or prospects of the
     Company or (B) the disclosure otherwise relates to a pending material
     business transaction that has not yet been publicly disclosed.

          (k)  Not later than the effective date of the applicable Registration
     Statement, the Company will provide a CUSIP number for the Initial
     Securities, the Exchange Securities or the Private Exchange Securities, as
     the case may be, and provide the applicable trustee with printed
     certificates for the Initial Securities, the Exchange Securities or the
     Private Exchange Securities, as the case may be, in a form eligible for
     deposit with The Depository Trust Company.

          (l)  The Company will comply with all rules and regulations of the
     Commission to the extent and so long as they are applicable to the
     Registered Exchange Offer or the Shelf Registration and will make generally
     available to its security holders (or otherwise provide in accordance with
     Section 11(a) of the Securities Act) an earnings

<Page>

                                                                               9

     statement satisfying the provisions of Section 11(a) of the Securities Act,
     no later than 45 days after the end of a 12-month period (or 90 days, if
     such period is a fiscal year) beginning with the first month of the
     Company's first fiscal quarter commencing after the effective date of the
     Registration Statement, which statement shall cover such 12-month period.

          (m)  The Company shall cause the Indenture to be qualified under the
     Trust Indenture Act of 1939, as amended, in a timely manner and containing
     such changes, if any, as shall be necessary for such qualification. In the
     event that such qualification would require the appointment of a new
     trustee under the Indenture, the Company shall appoint a new trustee
     thereunder pursuant to the applicable provisions of the Indenture.

          (n)  The Company may require each Holder of Securities to be sold
     pursuant to the Shelf Registration Statement to furnish to the Company such
     information regarding the Holder and the distribution of the Securities as
     the Company may from time to time reasonably require for inclusion in the
     Shelf Registration Statement, and the Company may exclude from such
     registration the Securities of any Holder that fails to furnish such
     information within a reasonable time after receiving such request.

          (o)  The Company shall enter into such customary agreements
     (including, if requested, an underwriting agreement in customary form) and
     take all such other action, if any, as the Holders of a majority of the
     Securities to be included in the Shelf Registration Statement shall
     reasonably request in order to facilitate the disposition of the Securities
     pursuant to any Shelf Registration.

          (p)  In the case of any Shelf Registration, the Company shall (i) make
     reasonably available for inspection by the Holders of the Securities, any
     underwriter participating in any disposition pursuant to the Shelf
     Registration Statement and any attorney, accountant or other agent retained
     by the Holders of the Securities or any such underwriter all relevant
     financial and other records, pertinent corporate documents and properties
     of the Company and (ii) cause the Company's officers, directors, employees,
     accountants and auditors to supply all relevant information reasonably
     requested by the Holders of the Securities or any such underwriter,
     attorney, accountant or agent in connection with the Shelf Registration
     Statement, in each case, as shall be reasonably necessary to enable such
     persons, to conduct a reasonable investigation within the meaning of
     Section 11 of the Securities Act; PROVIDED, HOWEVER, that the foregoing
     inspection and information gathering shall be coordinated on behalf of the
     Initial Purchasers by you and on behalf of the other parties, by one
     counsel designated by and on behalf of such other parties as described in
     Section 4 hereof. All such information shall be kept confidential by the
     recipients pursuant to a customary confidentiality agreement to be entered
     into by such recipient prior to releasing any such information.

          (q)  In the case of any Shelf Registration, the Company, if requested
     by any Holder of Securities covered thereby, shall cause (i) its counsel to
     deliver an opinion and updates thereof relating to the Securities in
     customary form addressed to such Holders and the managing underwriters, if
     any, thereof and dated, in the case of the initial opinion, the effective
     date of such Shelf Registration Statement, which opinions shall cover
     matters customarily addressed in opinions requested by underwriters in
     connection with underwritten offerings; (ii) its officers to execute and
     deliver all customary documents and certificates and updates thereof
     reasonably requested by any underwriters of the applicable Securities and
     (iii) its independent public accountants to provide to the selling Holders
     of the applicable Securities and any managing underwriter therefor a
     comfort letter in customary form and covering matters of the type

<Page>

                                                                              10

     customarily covered in comfort letters in connection with primary
     underwritten offerings, subject to receipt of appropriate documentation as
     contemplated, and only if permitted, by Statement of Auditing Standards No.
     72.

          (r)  In the case of the Registered Exchange Offer, if requested by any
     Initial Purchaser, the Company shall cause (i) its counsel to deliver to
     such Initial Purchaser a signed opinion, in customary form, in connection
     with the preparation of a Registration Statement and (ii) its independent
     public accountants to deliver to such Initial Purchaser a comfort letter,
     in customary form, meeting the requirements as to the substance thereof as
     set forth in Section 6(a) of the Purchase Agreement, with appropriate date
     changes.

          (s)  If a Registered Exchange Offer or a Private Exchange is to be
     consummated, upon delivery of the Initial Securities by Holders to the
     Company (or to such other Person as directed by the Company) in exchange
     for the Exchange Securities or the Private Exchange Securities, as the case
     may be, the Company shall mark, or caused to be marked, on the Initial
     Securities so exchanged that such Initial Securities are being canceled in
     exchange for the Exchange Securities or the Private Exchange Securities, as
     the case may be; in no event shall the Initial Securities be marked as paid
     or otherwise satisfied.

          (t)  The Company will use its reasonable best efforts to confirm that
     the ratings of the Initial Securities will apply to the Securities covered
     by a Registration Statement, if so requested by Holders of a majority in
     aggregate principal amount of Securities covered by such Registration
     Statement, or by the managing underwriters, if any.

          (u)  In the event that any broker-dealer registered under the Exchange
     Act shall underwrite any Securities or participate as a member of an
     underwriting syndicate or selling group or "assist in the distribution"
     (within the meaning of the Conduct Rules (the "RULES") of the National
     Association of Securities Dealers, Inc. ("NASD")) thereof, whether as a
     Holder of such Securities or as an underwriter, a placement or sales agent
     or a broker or dealer in respect thereof, or otherwise, the Company will
     assist such broker-dealer in complying with the requirements of such Rules,
     including, without limitation, by (i) if such Rules, including Rule 2720,
     shall so require, engaging a "qualified independent underwriter" (as
     defined in Rule 2720) to participate in the preparation of the Registration
     Statement relating to such Securities, to exercise usual standards of due
     diligence in respect thereto and, if any portion of the offering
     contemplated by such Registration Statement is an underwritten offering or
     is made through a placement or sales agent, to recommend the yield of such
     Securities, (ii) indemnifying any such qualified independent underwriter to
     the extent of the indemnification of underwriters provided in Section 5
     hereof and (iii) providing such information to such broker-dealer as may be
     required in order for such broker-dealer to comply with the requirements of
     the Rules.

          (v)  The Company shall use its reasonable best efforts to take all
     other steps necessary to effect the registration of the Securities covered
     by a Registration Statement contemplated hereby.

     4.   REGISTRATION EXPENSES.

     (a)  All expenses incident to the Company's performance of and compliance
with this Agreement (other than any underwriting discounts or commissions or
other such customary

<Page>

                                                                              11

selling expenses) will be borne by the Company, regardless of whether a
Registration Statement is ever filed or becomes effective, including without
limitation;

          (i) all registration and filing fees and expenses;

          (ii) all fees and expenses of compliance with federal securities and
     state "blue sky" or securities laws;

          (iii) all expenses of printing (including printing certificates for
     the Securities to be issued in the Registered Exchange Offer and the
     Private Exchange and printing of Prospectuses), messenger and delivery
     services and telephone;

          (iv) all fees and disbursements of counsel for the Company;

          (v) all application and filing fees in connection with listing the
     Exchange Securities on a national securities exchange or automated
     quotation system pursuant to the requirements hereof; and

          (vi) all fees and disbursements of independent certified public
     accountants of the Company (including the expenses of any special audit and
     comfort letters required by or incident to such performance).

The Company will bear its internal expenses (including, without limitation, all
salaries and expenses of its officers and employees performing legal or
accounting duties), the expenses of any annual audit and the fees and expenses
of any person, including special experts, retained by the Company.

     (b)  In connection with any Registration Statement required by this
Agreement, the Company will reimburse the Initial Purchasers and the Holders of
Transfer Restricted Securities who are tendering Initial Securities in the
Registered Exchange Offer or selling or reselling Securities pursuant to the
"Plan of Distribution" contained in the Exchange Offer Registration Statement or
the Shelf Registration Statement, as applicable, for the reasonable fees and
disbursements not to exceed $25,000 of not more than one counsel, who shall be
Cravath, Swaine & Moore unless another firm shall be chosen by the Holders of a
majority in principal amount of the Transfer Restricted Securities for whose
benefit such Registration Statement is being prepared.

     5.   INDEMNIFICATION.

     (a)  The Company will indemnify and hold harmless each Holder of the
Securities, any Participating Broker-Dealer and each person, if any, who
controls such Holder or such Participating Broker-Dealer within the meaning of
the Securities Act or the Exchange Act (each Holder, any Participating
Broker-Dealer and such controlling persons are referred to collectively as the
"INDEMNIFIED PARTIES") from and against any losses, claims, damages or
liabilities, joint or several, or any actions in respect thereof (including, but
not limited to, any losses, claims, damages, liabilities or actions relating to
purchases and sales of the Securities) to which each Indemnified Party may
become subject under the Securities Act, the Exchange Act or otherwise, insofar
as such losses, claims, damages, liabilities or actions arise out of or are
based upon any untrue statement or alleged untrue statement of a material fact
contained in a Registration Statement or prospectus or in any amendment or
supplement thereto or in any preliminary prospectus relating to a Shelf
Registration, or arise out of, or are based upon, the omission or alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein in light of the circumstances in which
they were made

<Page>

                                                                              12

not misleading, and shall reimburse, as incurred, the Indemnified Parties for
any legal or other expenses reasonably incurred by them in connection with
investigating or defending any such loss, claim, damage, liability or action in
respect thereof; PROVIDED, HOWEVER, that (i) the Company shall not be liable in
any such case to the extent that such loss, claim, damage or liability arises
out of or is based upon any untrue statement or alleged untrue statement or
omission or alleged omission made in a Registration Statement or prospectus or
in any amendment or supplement thereto or in any preliminary prospectus relating
to a Shelf Registration in reliance upon and in conformity with written
information pertaining to such Holder and furnished to the Company by or on
behalf of such Holder specifically for inclusion therein, (ii) with respect to
any untrue statement or omission or alleged untrue statement or omission made in
any preliminary prospectus relating to a Shelf Registration Statement, the
indemnity agreement contained in this subsection (a) shall not inure to the
benefit of any Holder or Participating Broker-Dealer from whom the person
asserting any such losses, claims, damages or liabilities purchased the
Securities concerned, to the extent that a prospectus relating to such
Securities was required to be delivered by such Holder or Participating
Broker-Dealer under the Securities Act in connection with such purchase and any
such loss, claim, damage or liability of such Holder or Participating
Broker-Dealer results from the fact that there was not sent or given to such
person, at or prior to the written confirmation of the sale of such Securities
to such person, a copy of the final prospectus if the Company had previously
furnished copies thereof to such Holder or Participating Broker-Dealer and (iii)
the Company shall not be liable in any such case to the extent such loss, claim,
damage or liability directly results from any prospectus delivered by any Holder
or Participating Broker-Dealer during a Suspension Period, but only if such
Holder or Participating Broker-Dealer received proper notice of such Suspension
Period as required by this Agreement; PROVIDED FURTHER, HOWEVER, that this
indemnity agreement will be in addition to any liability which the Company may
otherwise have to such Indemnified Party. The Company shall also indemnify
underwriters, their officers and directors and each person who controls such
underwriters within the meaning of the Securities Act or the Exchange Act to the
same extent as provided above with respect to the indemnification of the Holders
of the Securities if requested by such Holders.

     (b)  Each Holder of the Securities, severally and not jointly, will
indemnify and hold harmless the Company, its officers and directors and each
person, if any, who controls the Company within the meaning of the Securities
Act or the Exchange Act from and against any losses, claims, damages or
liabilities or any actions in respect thereof, to which the Company, its
officers and directors or any such controlling person may become subject under
the Securities Act, the Exchange Act or otherwise, insofar as such losses,
claims, damages, liabilities or actions arise out of or are based upon any
untrue statement or alleged untrue statement of a material fact contained in a
Registration Statement or prospectus or in any amendment or supplement thereto
or in any preliminary prospectus relating to a Shelf Registration, or arise out
of or are based upon the omission or alleged omission to state therein a
material fact necessary to make the statements therein not misleading, but in
each case only to the extent that the untrue statement or omission or alleged
untrue statement or omission was made in reliance upon and in conformity with
written information pertaining to such Holder and furnished to the Company by or
on behalf of such Holder specifically for inclusion therein; and, subject to the
limitation set forth immediately preceding this clause, shall reimburse, as
incurred, the Company for any legal or other expenses reasonably incurred by the
Company or any such controlling person in connection with investigating or
defending any loss, claim, damage, liability or action in respect thereof. This
indemnity agreement will be in addition to any liability which such Holder may
otherwise have to the Company or any of its controlling persons.

     (c)  Promptly after receipt by an indemnified party under this Section 5 of
notice of the commencement of any action or proceeding (including a governmental
investigation), such

<Page>

                                                                              13

indemnified party will, if a claim in respect thereof is to be made against the
indemnifying party under this Section 5, notify in writing the indemnifying
party of the commencement thereof; but the failure to notify the indemnifying
party will not, in any event, relieve it from any liability that it may have
under subsection (a) or (b) above except to the extent that it has been
materially prejudiced (through the forfeiture of substantive rights or defenses
or otherwise) by such failure; and provided further that the failure to notify
the indemnifying party shall not relieve it from any liability that it may have
to an indemnified party otherwise than under subsection (a) or (b) above. In
case any such action is brought against any indemnified party, and it notifies
the indemnifying party of the commencement thereof, the indemnifying party will
be entitled to participate therein and, to the extent that it may wish, jointly
with any other indemnifying party similarly notified, to assume the defense
thereof, with counsel reasonably satisfactory to such indemnified party (who
shall not, except with the consent of the indemnified party, be counsel to the
indemnified party in connection with such suit or the transactions giving rise
to such suit), and after notice from the indemnifying party to such indemnified
party of its election so to assume the defense thereof the indemnifying party
will not be liable to such indemnified party under this Section 5 for any legal
or other expenses, other than reasonable costs of investigation, subsequently
incurred by such indemnified party in connection with the defense thereof. No
indemnifying party shall, without the prior written consent of the indemnified
party, which consent shall not be unreasonably withheld or delayed, effect any
settlement of any pending or threatened action in respect of which any
indemnified party is or could have been a party and indemnity could have been
sought hereunder by such indemnified party unless such settlement (i) includes
an unconditional release of such indemnified party from all liability on any
claims that are the subject matter of such action, and (ii) does not include a
statement as to or an admission of fault, culpability or a failure to act by or
on behalf of any indemnified party.

     (d)  If the indemnification provided for in this Section 5 is unavailable
or insufficient to hold harmless an indemnified party under subsections (a) or
(b) above, then each indemnifying party shall contribute to the amount paid or
payable by such indemnified party as a result of the losses, claims, damages or
liabilities (or actions in respect thereof) referred to in subsection (a) or (b)
above in such proportion as is appropriate to reflect the relative fault of the
indemnifying party or parties on the one hand and the indemnified party on the
other in connection with the statements or omissions that resulted in such
losses, claims, damages or liabilities (or actions in respect thereof) as well
as any other relevant equitable considerations. The relative fault of the
parties shall be determined by reference to, among other things, whether the
untrue or alleged untrue statement of a material fact or the omission or alleged
omission to state a material fact relates to information supplied by the Company
on the one hand or such Holder or such other indemnified party, as the case may
be, on the other, and the parties' relative intent, knowledge, access to
information and opportunity to correct or prevent such statement or omission.
The amount paid by an indemnified party as a result of the losses, claims,
damages or liabilities referred to in the first sentence of this subsection (d)
shall be deemed to include any legal or other expenses reasonably incurred by
such indemnified party in connection with investigating or defending any action
or claim which is the subject of this subsection (d). Notwithstanding any other
provision of this Section 5(d), the Holders of the Securities shall not be
required to contribute any amount in excess of the amount by which the net
proceeds received by such Holders from the sale of the Securities pursuant to a
Registration Statement exceeds the amount of damages which such Holders have
otherwise been required to pay by reason of such untrue or alleged untrue
statement or omission or alleged omission. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act)
shall be entitled to contribution from any person who was not guilty of such
fraudulent misrepresentation. For purposes of this paragraph (d), each person,
if any, who controls such indemnified party within the meaning of the Securities
Act or the Exchange Act shall have the same rights to contribution as such
indemnified party and each director and

<Page>

                                                                              14

officer and each person, if any, who controls the Company within the meaning of
the Securities Act or the Exchange Act shall have the same rights to
contribution as the Company.

     (e)  The agreements contained in this Section 5 shall survive the sale of
the Securities pursuant to a Registration Statement and shall remain in full
force and effect, regardless of any termination or cancelation of this Agreement
or any investigation made by or on behalf of any indemnified party.

     6.   ADDITIONAL INTEREST UNDER CERTAIN CIRCUMSTANCES.

     (a)  Additional interest (the "ADDITIONAL INTEREST") with respect to the
Securities shall be assessed, subject to Section 6(b) hereof, as follows if any
of the following events occur (each such event in clauses (i) through (iv) below
being herein called a "REGISTRATION DEFAULT"):

          (i) any Registration Statement required by this Agreement is not filed
     with the Commission on or prior to the applicable Filing Deadline;

          (ii) any Registration Statement required by this Agreement is not
     declared effective by the Commission on or prior to the applicable
     Effectiveness Deadline;

          (iii) the Registered Exchange Offer has not been consummated on or
     prior to the Consummation Deadline; or

          (iv) any Registration Statement required by this Agreement has been
     declared effective by the Commission but (A) such Registration Statement
     thereafter ceases to be effective or (B) such Registration Statement or the
     related prospectus ceases to be usable in connection with resales of
     Transfer Restricted Securities during the periods specified herein because
     either (1) any event occurs as a result of which the related prospectus
     forming part of such Registration Statement would include any untrue
     statement of a material fact or omit to state any material fact necessary
     to make the statements therein in the light of the circumstances under
     which they were made not misleading, or (2) it shall be necessary to amend
     such Registration Statement or supplement the related prospectus, to comply
     with the Securities Act or the Exchange Act or the respective rules
     thereunder.

Each of the foregoing will constitute a Registration Default whatever the reason
for any such event and whether it is voluntary or involuntary or is beyond the
control of the Company or pursuant to operation of law or as a result of any
action or inaction by the Commission.

Additional Interest shall accrue on the Securities over and above the interest
set forth in the title of the Securities from and including the date on which
any such Registration Default shall occur to but excluding the date on which all
such Registration Defaults have been cured, at a rate of 0.25% per annum (the
"ADDITIONAL INTEREST RATE") for the first 90-day period immediately following
the occurrence of such Registration Default. The Additional Interest Rate shall
increase by an additional 0.25% per annum with respect to each subsequent 90-day
period until all Registration Defaults have been cured, up to a maximum
Additional Interest Rate of 1.0% per annum. Notwithstanding any provisions
herein to the contrary, if a Registered Exchange Offer has been consummated,
Additional Interest shall not accrue on any Security that is no longer a
Transfer Restricted Security.

     (b)  A Registration Default referred to in Section 6(a)(iv) hereof shall be
deemed not to have occurred and be continuing in relation to a Shelf
Registration Statement or the related prospectus if (i) such Registration
Default has occurred solely as a result of (x) the filing of a

<Page>

                                                                              15

post-effective amendment to such Shelf Registration Statement to incorporate
annual audited financial information with respect to the Company where such
post-effective amendment is not yet effective and needs to be declared effective
to permit Holders to use the related prospectus or (y) other material events,
with respect to the Company that would need to be described in such Shelf
Registration Statement or the related prospectus and (ii) in the case of clause
(y), the Company is proceeding promptly and in good faith to amend or supplement
such Shelf Registration Statement and related prospectus to describe such
events; PROVIDED, HOWEVER, that in any case if such Registration Default occurs
for a continuous period in excess of 60 days, Additional Interest shall be
payable in accordance with the above paragraph from the day such Registration
Default occurs until such Registration Default is cured or until the Company is
no longer required pursuant to this Agreement to keep such Registration
Statement or related prospectus in effect.

     (c)  Any amounts of Additional Interest due pursuant to Section 6(a) will
be payable in cash on the regular interest payment dates with respect to the
Securities. The amount of Additional Interest will be determined by multiplying
the applicable Additional Interest Rate by the principal amount of the
Securities and further multiplied by a fraction, the numerator of which is the
number of days such Additional Interest Rate was applicable during such period
(determined on the basis of a 360-day year comprised of twelve 30-day months),
and the denominator of which is 360.

     (d)  "TRANSFER RESTRICTED SECURITIES" means each Security until (i) the
date on which such Security has been exchanged by a person other than a
broker-dealer for a freely transferable Exchange Security in the Registered
Exchange Offer, (ii) following the exchange by a broker-dealer in the Registered
Exchange Offer of an Initial Security for an Exchange Security, the date on
which such Exchange Security is sold to a purchaser who receives from such
broker-dealer on or prior to the date of such sale a copy of the prospectus
contained in the Exchange Offer Registration Statement, (iii) the date on which
such Security has been effectively registered under the Securities Act and
disposed of in accordance with the Shelf Registration Statement or (iv) the date
on which such Security is distributed to the public pursuant to Rule 144 under
the Securities Act or is saleable pursuant to Rule 144(k) under the Securities
Act.

     7.   RULES 144 AND 144A. The Company shall use its reasonable best efforts
to file the reports required to be filed by it under the Securities Act and the
Exchange Act in a timely manner and, if at any time the Company is not required
to file such reports, it will, upon the written request of any Holder of
Securities, make publicly available other information so long as necessary to
permit sales of their securities pursuant to Rules 144 and 144A. The Company
covenants that it will take such further action as any Holder of Securities may
reasonably request in writing, all to the extent required from time to time to
enable such Holder to sell Securities without registration under the Securities
Act within the limitation of the exemptions provided by Rules 144 and 144A
(including the requirements of Rule 144A(d)(4)). The Company will provide a copy
of this Agreement to prospective purchasers of Initial Securities identified to
the Company by the Initial Purchasers upon request. If the Company ceases to be
a reporting company under the Exchange Act, upon the request of any Holder of
Initial Securities, the Company shall deliver to such Holder a written statement
as to whether it has complied with such requirements. Notwithstanding the
foregoing, nothing in this Section 7 shall be deemed to require the Company to
register any of its securities pursuant to the Exchange Act.

     8.   UNDERWRITTEN REGISTRATIONS. If any of the Transfer Restricted
Securities covered by any Shelf Registration are to be sold in an underwritten
offering, the investment banker or investment bankers and manager or managers
that will administer the offering ("MANAGING

<Page>

                                                                              16

UNDERWRITERS") will be selected by the Holders of a majority in aggregate
principal amount of such Transfer Restricted Securities to be included in such
offering and reasonably acceptable to the Company.

     No person may participate in any underwritten registration hereunder unless
such person (i) agrees to sell such person's Transfer Restricted Securities on
the basis reasonably provided in any underwriting arrangements approved by the
persons entitled hereunder to approve such arrangements and (ii) completes and
executes all questionnaires, powers of attorney, indemnities, underwriting
agreements and other documents reasonably required under the terms of such
underwriting arrangements.

     9.   MISCELLANEOUS.

     (a)  REMEDIES. The Company acknowledges and agrees that any failure by the
Company to comply with its obligations under Section 1 and 2 hereof may result
in material irreparable injury to the Initial Purchasers or the Holders for
which there is no adequate remedy at law, that it will not be possible to
measure damages for such injuries precisely and that, in the event of any such
failure, the Initial Purchasers or any Holder may obtain such relief as may be
required to specifically enforce the Company's obligations under Sections 1 and
2 hereof. The Company further agrees to waive the defense in any action for
specific performance that a remedy at law would be adequate. Notwithstanding the
foregoing, the Additional Interest is intended to constitute the sole monetary
damages that a Holder may collect as a result of any Registration Default.

     (b)  NO INCONSISTENT AGREEMENTS. The Company will not on or after the date
of this Agreement enter into any agreement with respect to its securities that
is inconsistent with the rights granted to the Holders in this Agreement or
otherwise conflicts with the provisions hereof. The rights granted to the
Holders hereunder do not in anyway conflict with and are not inconsistent with
the rights granted to the holders of the Company's securities under any
agreement in effect on the date hereof.

     (c)  AMENDMENTS AND WAIVERS. The provisions of this Agreement may not be
amended, modified or supplemented, and waivers or consents to departures from
the provisions hereof may not be given, except by the Company and the written
consent of the Holders of a majority in principal amount of the Securities
affected by such amendment, modification, supplement, waiver or consents.
Without the consent of the Holder of each Security, however, no modification may
change the provisions relating to the payment of Additional Interest.

     (d)  NOTICES. All notices and other communications provided for or
permitted hereunder shall be made in writing by hand delivery, first-class mail,
facsimile transmission, or air courier which guarantees overnight delivery:

          (1)  if to a Holder of the Securities, at the most current address
     given by such Holder to the Company.

          (2)  if to the Initial Purchasers:

          Credit Suisse First Boston LLC
          Eleven Madison Avenue
          New York, NY 10010-3629
          Fax No.: (212)325-8278
          Attention: Transactions Advisory Group

<Page>

                                                                              17

     with a copy to:

          Cravath, Swaine & Moore
          825 Eighth Avenue
          Worldwide Plaza
          New York, NY 10019-7475
          Fax No.: (212)474-3700
          Attention: Kris F.Heinzelman, Esq.

          (3) if to the Company:

          AmeriPath, Inc.
          7289 Garden Road
          Suite 200
          Riviera Beach, FL 33404
          Fax No.: (561)845-0129
          Attention: Chief Executive Officer

     with copies to:

          Welsh, Carson, Anderson & Stowe IX, L.P.
          320 Park Avenue
          Suite 2500
          New York, NY 10022
          Fax No.: (212)893-9566
          Attention: Paul B. Queally
                     D. Scott Mackesy

          and

          Reboul, MacMurray, Hewitt & Maynard
          45 Rockefeller Plaza
          New York, NY 10111
          Fax No.: (212)841-5725
          Attention: Othon A. Prounis, Esq.

     All such notices and communications shall be deemed to have been duly given
as follows: at the time delivered by hand, if personally delivered; three
business days after being deposited in the mail, postage prepaid, if mailed;
when receipt is acknowledged by recipient's facsimile machine operator, if sent
by facsimile transmission; and on the day delivered, if sent by overnight air
courier guaranteeing next day delivery.

     (e)  THIRD PARTY BENEFICIARIES. The Holders shall be third party
beneficiaries to the agreements made hereunder between the Company, on the one
hand, and the Initial Purchasers, on the other hand, and shall have the right to
enforce such agreements directly to the extent they may deem such enforcement
necessary or advisable to protect their rights or the rights of Holders
hereunder.

     (f)  SUCCESSORS AND ASSIGNS. This Agreement shall be binding upon the
Company and its successors and assigns.

<Page>

                                                                              18

     (g)  COUNTERPARTS. This Agreement may be executed in any number of
counterparts and by the parties hereto in separate counterparts, each of which
when so executed shall be deemed to be an original and all of which taken
together shall constitute one and the same agreement.

     (h)  HEADINGS. The headings in this Agreement are for convenience of
reference only and shall not limit or otherwise affect the meaning hereof.

     (i)  GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN
ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO PRINCIPLES
OF CONFLICTS OF LAWS.

     (j)  SEVERABILITY. If any one or more of the provisions contained herein,
or the application thereof in any circumstance, is held invalid, illegal or
unenforceable, the validity, legality and enforceability of any such provision
in every other respect and of the remaining provisions contained herein shall
not be affected or impaired thereby.

     (k)  SECURITIES HELD BY THE COMPANY. Whenever the consent or approval of
Holders of a specified percentage of principal amount of Securities is required
hereunder, Securities held by the Company or its affiliates (other than
subsequent Holders of Securities if such subsequent Holders are deemed to be
affiliates solely by reason of their holdings of such Securities) shall not be
counted in determining whether such consent or approval was given by the Holders
of such required percentage.

     (1)  SUBMISSION TO JURISDICTION; WAIVER OF IMMUNITIES. Each of the parties
hereto hereby submits to the non-exclusive jurisdiction of the Federal and state
courts in the Borough of Manhattan in The City of New York in any suit or
proceeding arising out of or relating to this Agreement or the transactions
contemplated hereby. To the extent that any such party may acquire any immunity
from jurisdiction of any court or from any legal process (whether through
service of notice, attachment prior to judgment, attachment in aid of execution,
execution or otherwise) with respect to itself or its property, it hereby
irrevocably waives such immunity in respect of this Agreement, to the fullest
extent permitted by law.

<Page>

If the foregoing is in accordance with your understanding of our agreement,
please sign and return to the Company a counterpart hereof, whereupon this
instrument, along with all counterparts, will become a binding agreement among
the several Initial Purchasers, the Company and the Guarantors in accordance
with its terms.

                                    Very truly yours,


                                    AMY ACQUISITION CORP,


                                    By /s/ D. Scott Mackesy
                                       ----------------------
                                       Name: D. Scott Mackesy
                                       Title: Vice President

                                    3-GEN DIAGNOSTIC LABORATORIES, INC.
                                    (a Utah corporation)
                                    AMERIPATH 5.01 (A) CORPORATION
                                    (a Texas not-for-profit corporation)
                                    AMERIPATH CARROLLTON, INC,
                                    (a Georgia corporation)
                                    AMERIPATH CINCINNATI, INC.
                                    (an Ohio corporation)
                                    AMERIPATH CLEVELAND, INC.
                                    (an Ohio corporation)
                                    AMERIPATH CONSOLIDATED LABS, INC.
                                    (a Florida corporation)
                                    AMERIPATH FLORIDA, INC.
                                    (a Florida corporation)
                                    AMERIPATH KENTUCKY, INC,
                                    (a Kentucky corporation)
                                    AMERIPATH LUBBOCK 5.01(A) CORPORATION
                                    (a Texas not-for-profit corporation)
                                    AMERIPATH MARKETING USA, INC.
                                    (a Florida corporation)
                                    AMERIPATH MICHIGAN, INC.
                                    (a Michigan corporation)
                                    AMERIPATH MISSISSIPPI, INC.
                                    (a Mississippi corporation)

<Page>

                                    AMERIPATH NEW ENGLAND, INC,
                                    (a Delaware corporation)
                                    AMERIPATH NEW YORK, INC.
                                    (a Delaware corporation)
                                    AMERIPATH NORTH CAROLINA, INC.
                                    (a North Carolina corporation)
                                    AMERIPATH OHIO, INC.
                                    (a Delaware corporation)
                                    AMERIPATH PAT 5.01(A) CORPORATION
                                    (a Texas not-for-profit corporation)
                                    AMERIPATH PCC, INC.
                                    (an Ohio corporation)
                                    AMERIPATH PENNSYLVANIA, INC.
                                    (a Pennsylvania corporation)
                                    AMERIPATH PHILADELPHIA, INC.
                                    (a New Jersey corporation)
                                    AMERIPATH SC, INC.
                                    (a South Carolina corporation)
                                    AMERIPATH SEVERANCE 5.01(A) CORPORATION
                                    (a Texas not-for-profit corporation)
                                    AMERIPATH, WISCONSIN, INC.
                                    (a Wisconsin corporation)
                                    AMERIPATH YOUNGSTOWN LABS, INC.
                                    (an Ohio corporation)
                                    AMERIPATH YOUNGSTOWN, INC.
                                    (an Ohio corporation)
                                    ANATOMIC PATHOLOGY SERVICES, INC.
                                    (an Oklahoma corporation)
                                    ARIZONA PATHOLOGY GROUP, INC.
                                    (an Arizona corporation)
                                    ARLINGTON PATHOLOGY ASSOCIATION 5.01(A)
                                    CORPORATION
                                    (a Texas not-for-profit corporation)
                                    BEN F. MARTIN, M.D., F.C.A.P., INC.
                                    (a Mississippi corporation)
                                    CALIFORNIA PATHOLOGY CONSULTANTS
                                    OF AMERICA, INC.
                                    (a Tennessee corporation)

<Page>

                                    CPA I, INC.
                                    (a Tennessee corporation)
                                    CPA II, INC.
                                    (a Tennessee corporation)
                                    DERMATOPATHOLOGY SERVICES, INC.
                                    (an Alabama corporation)
                                    DERMPATH, INC.
                                    (a Delaware corporation)
                                    DFW 5.01(A) CORPORATION
                                    (a Texas not-for-profit corporation)
                                    DIAGNOSTIC PATHOLOGY MANAGEMENT
                                    SERVICES, INC.
                                    (an Oklahoma corporation)
                                    GEORGIA PATHOLOGY CONSULTANTS OF
                                    AMERICA, INC.
                                    (a Tennessee corporation)
                                    J. DAVID SMITH, M.D., INC.
                                    (a Georgia corporation)
                                    JOHN H. PARKER, JR., M.D., F.C.A.P., INC.
                                    (a Mississippi corporation)
                                    KAILASH B. SHARMA, M.D., INC.
                                    (a Georgia corporation)
                                    KATHARINE LIU, M.D., INC.
                                    (a Georgia corporation)
                                    NAPA 5.01(A) CORPORATION
                                    (a Texas not-for-profit corporation)
                                    OCMULGEE MEDICAL PATHOLOGY ASSOCIATION, INC.
                                    (a Georgia corporation)
                                    O'QUINN MEDICAL PATHOLOGY ASSOCIATION, INC.
                                    (a Georgia corporation)
                                    PATHOLOGY AFFILIATED SERVICES, INC.
                                    (a Texas corporation)
                                    PATHOLOGY CONSULTANTS OF AMERICA, INC.
                                    (a Tennessee corporation)
                                    PATHSOURCE, INC.
                                    (a Delaware corporation)

<Page>

                                    PCA OF COLUMBUS, INC.
                                    (a Tennessee corporation)
                                    PCA OF DENVER, INC.
                                    (a Tennessee corporation)
                                    PCA OF LOS GATOS, INC. (a
                                    Tennessee corporation)
                                    PCA OF MEMPHIS, INC.
                                    (a Tennessee corporation)
                                    PCA OF NASHVILLE, INC.
                                    (a Tennessee corporation)
                                    PCA OF ST. LOUIS II, INC.
                                    (a Tennessee corporation)
                                    PCA SOUTHEAST II, INC.
                                    (a Tennessee corporation)
                                    PCA/APR ACQUISITION CORP.
                                    (a Tennessee corporation)
                                    PETER G. KLACSMANN, M.D., INC.
                                    (a Georgia corporation)
                                    SHARON G. DASPIT, M.D., INC.
                                    (a Georgia corporation)
                                    SHOALS PATHOLOGY ASSOCIATES, INC.
                                    (an Alabama corporation)
                                    SIMPSON PATHOLOGY 5.01(A)
                                    CORPORATION
                                    (a Texas not-for-profit corporation)
                                    STRIGEN, INC.
                                    (a Utah corporation)
                                    TID ACQUISITION CORP.
                                    (a Delaware corporation)
                                    TXAR 5.01(A) CORPORATION
                                    (a Texas not-for-profit corporation)

                                      by: /s/ Gregory A. Marsh
                                          -------------------------
                                          Name: Gregory A. Marsh
                                          Title: Vice President

<Page>

                                    ROCKY MOUNTAIN PATHOLOGY, L.L.C.

                                      by: /s/ Gregory A. Marsh
                                          -------------------------
                                          Name: Gregory A. Marsh
                                          Title: Manager

                                    AMERIPATH, LLC

                                      by: /s/ Gregory A. Marsh
                                          -------------------------
                                          Name: Gregory A. Marsh
                                          Title: Manager

                                    API NO. 2, LLC

                                      by: /s/ Gregory A. Marsh
                                          -------------------------
                                          Name: Gregory A. Marsh
                                          Title: Manager

                                    AMERIPATH INDIANA, LLC

                                      by: AMERIPATH, INC.
                                          (as Managing Member)

                                      by: /s/ Gregory A. Marsh
                                          -------------------------
                                          Name: Gregory A. Marsh
                                          Title: Chief Financial Officer

<Page>

                                    COLUMBUS PATHOLOGY ASSOCIATES

                                      by: CPA I, INC.
                                          (as General Partner)

                                      by: /s/ Gregory A. Marsh
                                          -------------------------
                                          Name: Gregory A. Marsh
                                          Title: Vice President

                                    NUCLEAR MEDICINE & PATHOLOGY ASSOCIATES

                                      by: SHARON G. DASPIT, M.D., INC.
                                          (as General Partner)

                                      by: /s/ Gregory A. Marsh
                                          -------------------------
                                          Name: Gregory A. Marsh
                                          Title: Vice President

                                    AMERIPATH TEXAS, LP

                                      by: AMERIPATH, LLC.
                                          (as General Partner)

                                      by: /s/ Gregory A. Marsh
                                          -------------------------
                                          Name: Gregory A. Marsh
                                          Title: Manager

<Page>

The foregoing Registration Rights Agreement is hereby confirmed and accepted as
of the date first above written.

CREDIT SUISSE FIRST BOSTON LLC,
as representative for the Initial Purchasers,

By: /s/ Craig R. Callen
    --------------------------
    Name : Craig R. Callen
    Title: Managing Director

<Page>

                                                                         ANNEX A

Each broker-dealer that receives Exchange Securities for its own account
pursuant to the Exchange Offer must acknowledge that it will deliver a
prospectus in connection with any resale of such Exchange Securities. The Letter
of Transmittal states that by so acknowledging and by delivering a prospectus, a
broker-dealer will not be deemed to admit that it is an "underwriter" within the
meaning of the Securities Act. This Prospectus, as it may be amended or
supplemented from time to time, may be used by a broker-dealer in connection
with resales of Exchange Securities received in exchange for Initial Securities
where such Initial Securities were acquired by such broker-dealer as a result of
market-making activities or other trading activities. The Company has agreed
that, for a period of 180 days after the Expiration Date (as defined herein), it
will make this Prospectus available to any broker-dealer for use in connection
with any such resale. See "Plan of Distribution."

<Page>

                                                                         ANNEX B

Each broker-dealer that receives Exchange Securities for its own account in
exchange for Initial Securities, where such Initial Securities were acquired by
such broker-dealer as a result of market-making activities or other trading
activities, must acknowledge that it will deliver A prospectus in connection
with any resale of such Exchange Securities. See "Plan of Distribution."

<Page>

                                                                         ANNEX C

                              PLAN OF DISTRIBUTION

     Each broker-dealer that receives Exchange Securities for its own account
pursuant to the Exchange Offer must acknowledge that it will deliver a
prospectus in connection with any resale of such Exchange Securities. This
Prospectus, as it may be amended or supplemented from time to time, may be used
by a broker-dealer in connection with resales of Exchange Securities received in
exchange for Initial Securities where such Initial Securities were acquired as a
result of market-making activities or other trading activities. The Company has
agreed that, for a period of 180 days after the Expiration Date, it will make
this prospectus, as amended or supplemented, available to any broker-dealer for
use in connection with any such resale. In addition, until, 200, all dealers
effecting transactions in the Exchange Securities may be required to deliver a
prospectus.(1)

     The Company will not receive any proceeds from any sale of Exchange
Securities by broker-dealers. Exchange Securities received by broker-dealers for
their own account pursuant to the Exchange Offer may be sold from time to time
in one or more transactions in the over-the-counter market, in negotiated
transactions, through the writing of options on the Exchange Securities or a
combination of such methods of resale, at market prices prevailing at the time
of resale, at prices related to such prevailing market prices or negotiated
prices. Any such resale may be made directly to purchasers or to or through
brokers or dealers who may receive compensation in the form of commissions or
concessions from any such broker-dealer or the purchasers of any such Exchange
Securities. Any broker-dealer that resells Exchange Securities that were
received by it for its own account pursuant to the Exchange Offer and any broker
or dealer that participates in a distribution of such Exchange Securities may be
deemed to be an "underwriter" within the meaning of the Securities Act and any
profit on any such resale of Exchange Securities and any commission or
concessions received by any such persons may be deemed to be underwriting
compensation under the Securities Act. The Letter of Transmittal states that, by
acknowledging that it will deliver and by delivering a prospectus, a
broker-dealer will not be deemed to admit that it is an "underwriter" within the
meaning of the Securities Act.

     For a period of 180 days after the Expiration Date the Company will
promptly send additional copies of this Prospectus and any amendment or
supplement to this Prospectus to any broker-dealer that requests such documents
in the Letter of Transmittal. The Company has agreed to pay all expenses
incident to the Exchange Offer (including the expenses of one counsel for the
Holders of the Securities) other than commissions or concessions of any brokers
or dealers and will indemnify the Holders of the Securities (including any
broker-dealers) against certain liabilities, including liabilities under the
Securities Act.

----------
      (1) In addition, the legend required by Item 502(e) of Regulation S-K
will appear on the inside front cover page of the Exchange Offer prospectus
below the Table of Contents.

<Page>

                                                                         ANNEX D

[ ]   CHECK HERE IF YOU ARE A BROKER-DEALER AND WISH TO RECEIVE 10 ADDITIONAL
COPIES OF THE PROSPECTUS AND 10 COPIES OF ANY AMENDMENTS OR SUPPLEMENTS THERETO.

      Name:

      Address:

If the undersigned is not a broker-dealer, the undersigned represents that it is
not engaged in, and does not intend to engage in, a distribution of Exchange
Securities. If the undersigned is a broker-dealer that will receive Exchange
Securities for its own account in exchange for Initial Securities that were
acquired as a result of market-making activities or other trading activities, it
acknowledges that it will deliver a prospectus in connection with any resale of
such Exchange Securities; however, by so acknowledging and by delivering a
prospectus, the undersigned will not be deemed to admit that it is an
"underwriter" within the meaning of the Securities Act.

<Page>

                                                                      SCHEDULE 1


                              SUBSIDIARY GUARANTORS

<Table>
<Caption>
               NAME                                       JURISDICTION
               ----                                       ------------
<S>                                                      <C>
3-Gen Diagnostic Laboratories, Inc.                           Utah
AmeriPath, LLC                                              Delaware
AmeriPath 5.01(a) Corporation                                 Texas
AmeriPath Carrollton, Inc.                                   Georgia
AmeriPath Cincinnati, Inc.                                    Ohio
AmeriPath Cleveland, Inc.                                     Ohio
AmeriPath Consolidated Labs, Inc.                            Florida
AmeriPath Florida, Inc.                                      Florida
AmeriPath Indiana, LLC                                       Indiana
AmeriPath Kentucky, Inc.                                    Kentucky
AmeriPath Lubbock 5.01(a) Corporation                         Texas
AmeriPath Marketing USA, Inc.                                Florida
AmeriPath Michigan, Inc.                                    Michigan
AmeriPath Mississippi, Inc.                                Mississippi
AmeriPath New York, Inc.                                    Delaware
AmeriPath North Carolina, Inc.                           North Carolina
AmeriPath New England, Inc.                                 Delaware
AmeriPath Ohio, Inc.                                        Delaware
AmeriPath PAT 5.01(a) Corporation                             Texas
AmeriPath PCC, Inc.                                           Ohio
AmeriPath Pennsylvania, Inc.                              Pennsylvania
AmeriPath Philadelphia, Inc.                               New Jersey
AmeriPath SC, Inc.                                       South Carolina
AmeriPath Severance 5.0l(a) Corporation                       Texas
AmeriPath Texas, LP                                         Delaware
AmeriPath Youngstown Labs, Inc.                               Ohio
AmeriPath Youngstown, Inc.                                    Ohio
AmeriPath, Wisconsin, Inc.                                  Wisconsin
Anatomic Pathology Services, Inc.                           Oklahoma
API No. 2, LLC                                              Delaware
Arizona Pathology Group, Inc.                                Arizona
</Table>

<Page>

<Table>
<S>                                                       <C>
Arlington Pathology Association 5.01(a)
Corporation                                                  Texas
Ben F. Martin, M.D., F.C.A.P, Inc.                        Mississippi
California Pathology Consultants of America, Inc.          Tennessee
Columbus Pathology Associates                             Mississippi
CPA I, Inc.                                                Tennessee
CPA II, Inc.                                               Tennessee
Dermatopathology Services, Inc.                             Alabama
Dermpath, Inc.                                             Delaware
DFW 5.01(a) Corporation                                      Texas
Diagnostic Pathology Management Services, Inc.             Oklahoma
Georgia Pathology Consultants of America, Inc.             Tennessee
J. David Smith, M.D., Inc.                                  Georgia
John H. Parker, Jr., M.D., F.C.A.P., Inc.                 Mississippi
Kailash B. Sharma, M.D., Inc.                               Georgia
Katharine Liu, M.D., Inc.                                   Georgia
NAPA 5.01(a) Corporation                                     Texas
Nuclear Medicine and Pathology Associates                   Georgia
Ocmulgee Medical Pathology Association, Inc.                Georgia
O'Quinn Medical Pathology Association, Inc.                 Georgia
Pathology Affiliated Services, Inc.                          Texas
Pathology Consultants of America, Inc.                     Tennessee
PathSOURCE, Inc.                                           Delaware
PCA of Columbus, Inc.                                      Tennessee
PCA of Denver, Inc.                                        Tennessee
PCA of Los Gatos,Inc.                                      Tennessee
PCA of Memphis, Inc.                                       Tennessee
PCA of Nashville, Inc.                                     Tennessee
PCA of St. Louis II, Inc.                                  Tennessee
PCA Southeast II, Inc.                                     Tennessee
PCA/APR Acquisition Corporation                            Tennessee
Peter G. Klacsmann, M.D., Inc.                              Georgia
Rocky Mountain Pathology, L.L.C.                             Utah
Sharon G. Daspit, M.D., Inc.                                Georgia
Shoals Pathology Associates, Inc.                           Alabama
</Table>

<Page>

<Table>
<S>                                                        <C>
Simpson Pathology 5.01(a) Corporation                        Texas
Strigen, Inc.                                                Utah
TID Acquisition Corporation                                Delaware
TXAR 5.01(a) Corporation                                     Texas
</Table>